Diabetic neuropathy

Zhurnal Nevropatolgii i Psikhiatrii im. S S Korsakova

Volumn 100, Issue 10, 2000, Pages 57-64

  Balabolkin, M I ^a   Kreminskaya, V M ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIOXIDANT; BENPHOTHIAMINE; DRUG DERIVATIVE; IMMUNOLOGICAL ADJUVANT; NICOTINAMIDE ADENINE DINUCLEOTIDE; NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; NITRIC OXIDE SYNTHASE; THIAMINE; THIOCTIC ACID;

ACUPUNCTURE; ARTICLE; DIABETIC NEUROPATHY; ENZYMOLOGY; HOSPITALIZATION; HUMAN; LIPID PEROXIDATION; METABOLISM; MULTIMODALITY CANCER THERAPY; PARESTHESIA; PHYSIOLOGY; TREATMENT OUTCOME;

ACUPUNCTURE THERAPY; ADJUVANTS, IMMUNOLOGIC; ANTIOXIDANTS; COMBINED MODALITY THERAPY; DIABETIC NEUROPATHIES; HUMANS; LIPID PEROXIDATION; NAD; NADP; NITRIC OXIDE SYNTHASE; PARESTHESIA; SEVERITY OF ILLNESS INDEX; THIAMINE; THIOCTIC ACID; TREATMENT OUTCOME;

EID: 0033641432     PISSN: 00444588     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Bravenboer B., Herdrikse P.H., Oey P.I., et al. Randomised double-blind placebo controlled trial to evaluate the effect of the ACTH analog ORG 2766 in IDDM patients with neuropathy. Diabetologia 1994; 39: 408-413.
2. Coscelli C., Cucinotta D., Santeusano F., Fedele D. Safety of tolresat in diabetic neuropathy: Italian multicentre surveillance study. Clin Drug Invest 1995; 10: 235-241.
3. Giugliano D., Misso L., Acampora R. et al. Tolrestat in the primary prevention of diabetic neuropathy. Diabetes Care 1995: 18: 538-541.
4. Keen K., Payan J., Allawi J. et al. Treatment of diabetic neuropathy with gamma linolenic acid. Diabetes Care 1993; 16: 8-15.
5. Krendel D.A., Costigan D.A., Hopkins L.S. Arch Neurol 1995; 52: 1053-1061.
6. Le Beau J.M., Liuzzi F.J., Depto A.J., Vinic A.I. Differential laminin gene expression in dorsal root ganglion neurons and non-neuronal cells. Exp Neurol 1994; 127: 1-8.
7. Malik R.A., Tesfaye S., Thopmson S.D. et al. Transperineurial capillary abnormalities in the sural nerve of patients with diabetic neuropathy. Microvasc Res 1994; 48: 236-245.
8. Pfeifer M.A., Ross D.R., Schrage J.P. et al. A highly successful and novel model for treatment of chronic painful diabetic peripheral neuropathy. Diabetes Care 1993: 1103-1115.
9. Rubin R. T., Altman W.M., Mendelson D.N. Health care expenditures for people with diabetes mellitus. 1992. J Clin Endocrinol Metab 1994; 78: 4: 809A-809F.
10. Said G., Goulon-Gorean C., Lacroix C., Moulonguet A. Nerve biopsy findings in different patterns of proximal diabetic neuropathy. Ann Neurol 1994; 35: 559-596.
11. Sindrup S.H. Antidepressants in the treatment of diabetic neuropathy symptoms. Dan Med Bull 1994; 41: 66-78.
12. Strodter D., Lehman E., Lehmann U. et al. The influence of thiotic acid on metabolism and function of the diabetic heart. Diabetes Res Clin Pract 1995; 29: 19-26.
13. Strowing S.M., Raskin P. Glycemic control and the complications of diabetes International texstbook of diabetes mellitus. Eds. K.G.M.M. Alberti et al. Wiley 1997; 2: 1321-1338.
14. Vinic A.L. Leichter S.B., Pittenger G.L. et al. Phospholipid and glutamine acid antibodies in diabetic neuropathy. Diabetes Care 1995; 18: 1225-1232.
15. Ziegler D., Hanefeld M., Ruhnau K.J. et al. The ALADIN Study: Treatment of symptomatic diabetic peripheral neuropathy with the antioxidant α-lipoic acid. Diabetologia 1995: 38: 1425-1433.